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Abstract 
Ameloblastoma  is  a  benign  odontogenic
tumor. These are usually asymptomatic until a
large size is attained. Ameloblastoma has ten-
dency to spread locally and has a high recur-
rence rate. Majority of ameloblastomas (80%)
arise from the mandible. Ameloblastoma aris-
ing from anterior mandibular region (symph-
ysis-menti) is rare. Very few cases of midline
anterior ameloblastomas are reported in the
literature. They often require wide local exci-
sion.  Reconstruction  of  mandible  in  these
cases  is  challenging.  We  present  a  case  of
mandibular ameloblastoma arising from sym-
physis-menti. Patient underwent wide surgical
excision of the tumor followed by immediate
reconstruction using free fibular vascular flap,
stabilized with titanium reconstructive plates.
A brief case report ands review of literature is
presented.
Introduction
Ameloblastoma  (Adamantinoma)  is  a
benign  odontogenic  epithelial  tumor.1 It
accounts for 1% of all endodermal tumors and
11% of odontogenic tumors. It arises most fre-
quently  from  the  residue  of  dental  ledge,
enamel organ or Malassez epithelial rests or
basal layer of oral epithelium.2-4The exact aeti-
ology  is  not  known.2 The  tumor  frequently
develops in the mandible (80%), maxilla (16%)
while peripheral adamantinoma located in the
soft tissue account for remaining 4%.2 In the
mandible,  it  frequently  involves  molar  &
mandibular angle (70%), premolar (20%) and
rarely anterior region (10%).2 It is a slow grow-
ing  tumor,  with  equal  gender  prevalence.
These are usually asymptomatic and presents
with bony deformity. 
Preoperative  imaging  including  orthopan-
togram  (OPG),  computed  tomography  (CT
scan), magnetic resonance imaging (MRI) and
3D CT scan play important role in planning
extent of surgical resection. Treatment modal-
ities  include  surgical  excision,  enucleation,
curettage,  cryotherapy,  radiotherapy  and
chemotherapy.  Wide  surgical  excision  with
safe  margins  is  the  preferred  treatment
method. 
We present a rare case of anterior mandibu-
lar ameloblastoma (<10%) arising from sym-
physis-menti, for which segmental resection of
mandible was done with simultaneous recon-
struction using free fibula vascular flap stabi-
lized with reconstructive titanium plates.
Case Report
A  42-year-old  male  patient  was  admitted
with lower jaw swelling of three years dura-
tion. Initially he was asymptomatic, however
he  then  complained  of  bony  deformity  with
gradual spontaneous fall of lower central teeth,
difficulty in opening mouth and chewing food
since 3-4 months.
On examination, patient had a huge bony
tumor  of  the  mandible  with  a  parchment
crunch feel. It was extending from left second
premolar to the first premolar on right, pre-
dominantly  affecting  anterior  segment  of
mandible.  Overlying  skin  was  freely  mobile
(Figure 1a). Intraorally, tumor was extending
into sublingual region displacing tongue with
loss of lower incisor and canine teeth (Figure
1b). There were few mucosal ulcerations. No
cervical lymphadenopathy was noted.
OPG  displayed  a  multilocular,  osteolytic
defect predominantly around midline extend-
ing to left and right causing marked expansion
in the lower part with thinning of cortex of the
mandible. A 3D CT scan revealed the presence
of an expansive, multilocular, lytic lesion cen-
tered on the symphysis-menti (Figure 2a) and
extending  into  parasymphyseal  region  and
into the proximal body of the mandible on the
left side (Figures 2b and 2c). It was extending
exophytically  both  anteriorly  and  inferiorly
measuring 7.4¥4.7¥4.7 cm in size.
Wide  local  excision  of  central  part  of
mandible  was  performed  with  simultaneous
reconstruction using free fibular vascular flap,
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Figure 1. Preoperative external appearance
of lower jaw swelling. (a) Frontal view. (b)
Intraoral  view  showing  tumor  extending
into sublingual region. 
Figure 2. 3D computed tomography revealing large expansile, multiseptate, lytic lesion
involving (a) anterior portion of mandible. (b, c) tumor extension into left lateral part of
the mandible. 
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stabilized  with  a  titanium  reconstructive
plates (Figure 3).        
Gross  specimen  showed  few  cystic  areas
with more solid component (Figure 4a) and cut
section revealed cystic areas with few areas of
necrosis and hemorrhage (Figure 4b). 
Histology  confirmed  ameloblastoma  with
negative  free  margin  (Figure  5a).
Immunohistochemistry  report  revealed
ameloblastoma positive for cytokeratin 5 and 6
(Figure 5b) and cytokeratin 14, negative for
CD 68, cytokeratin 8 and 18 and calretinin.
Postoperative course was uneventful. Follow
up  x-rays  showed  almost  normal  contour  of
lower  jaw  (Figure  6a)  and  good  cosmesis
(Figure 6b) with normal jaw movements and
normal healing bone graft. Patient is on follow
up for 1 year with and 3D CT scan showed no
local recurrence (Figures 6c and 6d). Patient is
on  follow  up  for  prosthetic  rehabilitation  to
restore  missing  tooth  (dental  implantation).
Present  case  highlights  the  importance  of
functional reconstruction along with cosmesis
in an adult male after wide excision of anteri-
or mandible.
Discussion
Ameloblastoma (from the early English word
amel,  meaning  enamel  and  the  greek  word
blastos, meaning germ) is a rare, benign odon-
togenic  tumor  of  epithelial  origin.  It  was
described in 1827 by Cusack and designated as
an Adamantinoma in 1885 by the French physi-
cian Louis-Charles Malassez and renamed as
Ameloblastoma in 1930 by Ivey and Churchill.1
Unicystic ameloblastoma, a variant was first
described by Robinson and Martinez.5
Ameloblastoma  are  usually  diagnosed
between the 4thand 5thdecades of life except in
unicystic variety (accounts for 6%), which is
diagnosed  between  the  ages  of  20  and  30
years.  No  gender  predominance  is  noted.6
About 10-15% of the tumors are often linked to
a nonerupted tooth (impacted wisdom tooth).7
Ameloblastoma are usually asymptomatic and
found on routine dental x-rays; however they
present with jaw expansion. Its slow but relent-
less  growth  may  cause  movement  of  tooth
roots or root resorption. In our case patient
had  lower  jaw  swelling  with  bony  deformity
and gradual spontaneous fall of lower central
incisor and canine teeth, difficulty in opening
mouth and chewing food.
Radiographically, it can either be unicystic
intraosseous,  multicystic,  solid  intraosseous
(80-90%) or peripheral.8 These are histologi-
cally  classified  into  follicular,  granular,  lexi-
form, desmoplastic, basal cell and acanthoma-
tous variety.9 Diagnosis is usually made by fine
needle  aspiration,  which  reveals  palisaded
basal  cell  layer  with  stellate  reticulum  like
epithelium.  Immunohistochemistry  study
revealed tumor cells positive for keratin and
express CK 5, 6 and 14, few cells also reactive
for  cytokeratin  8,  18  and  19.  Calretinin  is
expressed  by  certain  solid  and  multicystic
ameloblastoma.  Granular  cell  ameloblastoma
specifically express CD 56 and S-100 protein
along  with  keratins.  In  the  present  case,
ameloblastoma was of follicular variety and on
immunohistochemistry study tumor cells, pos-
itive for cytokeratins 5 and 6 and cytokeratin
14, negative for CD 68, cytokeratin 8 and 18
and calretinin.
According to World Health Organization his-
tological typing of odontogenic tumor, second
edition 1992, ameloblastoma are further sub-
classified as summarized in Table 1.10
Ameloblastoma  rarely  shows  malignant
change, accounting for less than 1% of cases.
Malignant ameloblastoma may arise de novoor
Case Report
Table 1. Ameloblastoma subclassification, according to World Health Organization (1992).
Benign
Odontogenic epithelium without  Odontogenic epithelium with 
odontogenic ectomesenchyme odontogenic ectomesenchyme
with or without dental hard tissue formation
i. Ameloblastoma; i. Ameloblastoma fibroma;
ii. Squamous odontogenic tumor; ii. Ameloblastoma fibrodentinoma and fibro-odontoma;
iii. Clear cell odontogenic tumor; iii. Odontoameloblastoma;
iv. Calcified epithelial odontogenic tumor. iv. Adenomatoid odontogenic tumor;
v. Complex/ compound odontoma;
vi. Calcified odontogenic cyst.
Malignant
Odontogenic sarcoma Odontogenic fibrosarcoma Odontogenic carcinosarcoma
i. Malignant ameloblastoma; i. Ameloblastic fibrosarcoma;
ii. Primary intraosseous carcinoma; ii. Ameloblastic fibrodentinosarcoma and fibroodontosarcoma.
iii. Malignant change in odontogenic cyst.
Figure 3. Autogenous osseomyocutaneous
fibular flap (arrow) shaped into mandibu-
lar  contour  with  reconstructive  titanium
plates (arrow head).
Figure  4.  Specimen  showing  (a)  tumor
involving anterior and left lateral segment
of the mandible and (b) cut section show-
ing  predominant  solid  component  with
few cystic areas.
Figure 5. (a) Histology showing basal layer
with stellate reticulum like epithelium. (b)
Tumor cells positive for cytokeratin 5 and 6.
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transformation of pre-existing ameloblastoma.
These usually occur in adults, aggressive in
nature with poor outcome. Most common site
of spread includes lung, cervical lymph nodes
and rarely brain. 
Surgery is the mainstay of treatment and
involves complete removal of tumor with nega-
tive margin of 15-20 mm.2 Segmental resec-
tion, hemi resection or complete enucleation
of  mandible  with  simultaneous  and  final
reconstruction  of  the  postoperative  defect
gives  normal  contour  and  better  functional
ability  which  is  only  possible  when  the
patient’s general condition is good. A free vas-
cularized fibula flap offers the best option for
mandibular  reconstruction  and  subsequent
dental  implantation.  The  autogenic  bone
transplant from the iliac ala, fibula, scapula or
radius is currently believed to be one of the
best methods for mandible reconstruction. In
most cases described in literature the results
are satisfactory both in terms of functionality
and  aesthetics.  There  is  little  information
available in the literature regarding the role of
radiotherapy, as a useful modality of treatment
in case ameloblastoma.11Role of chemotherapy
is not yet well defined, either single agent or
combination chemotherapy have been used for
palliation in patients with irresectable metas-
tasis  but  only  few  reports  showed  little
response (Cisplatin and Paclitaxel).12 Among
surgical  modalities,  recurrence  rates  were
3.6% for wide resection, 30.5% for enucleation
and  16%  for  enucleation  followed  by  use  of
Carnoy’s solution. Few reports are available in
the  literature  regarding  recurrence  of
ameloblastoma  in  the  grafted  bone.  Hence
long-term follow up is recommended for more
than 10 years at regular intervals after appro-
priate surgical operation. Patient should be on
clinical and radiological follow up irrespective
of the treatment done. 
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Case Report
Figure  6.  Post-operative  (a)  X-ray  revealing  normal  anatomical  bone  contour  of  the
mandible supported by reconstructive plates and (b) anterior appearance of mandibular
region on day 14 (good cosmesis). (c) Reconstructed Postoperative 3D CT scan (at 1 year
follow up) revealing no local recurrence. Red arrows showing titanium reconstructive
plates, (d) mandible with free fibular vascular flap.
Non-commercial use only